Literature DB >> 23982770

The Parental Cancer Questionnaire: scale structure, reliability, and validity.

Janelle V Levesque1, Darryl J Maybery.   

Abstract

PURPOSE: This study aims to determine the principal component structure of the Parental Cancer Questionnaire (PCQ) in a sample of adult children whose parents had cancer and to illustrate the validity and reliability of subscales.
METHOD: The PCQ was administered to 311 adult children of parents with cancer along with the Posttraumatic Growth Inventory, Carer's Assessment of Difficulties Scale, Carer's Assessment of Satisfactions Scale, Reaction to Diagnosis of Cancer Questionnaire, and the Grief Diagnostic Instrument.
RESULTS: Exploratory Principal Components Analysis identified three dimensions of the parental cancer experience (explaining 51 % of the variance amongst scale items). The components were parental cancer benefits (e.g. 'I became closer to my sick parent during his/her cancer.'), emotional experiences (e.g. 'I was devastated by my parent's cancer.'), and caregiver strain (e.g. 'I feel/felt there was nobody to assist or support me in caring for my parent.'). Convergent and discriminant validity were demonstrated by meaningful correlations with other related measures (ranging from 0.14 to 0.68), and strong internal reliability was shown with Cronbach α between 0.87 and 0.91.
CONCLUSIONS: The PCQ has a clear three-component structure and demonstrates good reliability. The measure has excellent face, content, convergent, and discriminant validity, indicating a structure suitable for use in future research. The measure appears to be a useful measure of the experience of parental cancer for adult children.

Entities:  

Mesh:

Year:  2013        PMID: 23982770     DOI: 10.1007/s00520-013-1935-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  31 in total

1.  Existential plight of adult daughters following their mother's breast cancer diagnosis.

Authors:  Victoria H Raveis; Sheindy Pretter
Journal:  Psychooncology       Date:  2005-01       Impact factor: 3.894

Review 2.  Positive change following trauma and adversity: a review.

Authors:  P Alex Linley; Stephen Joseph
Journal:  J Trauma Stress       Date:  2004-02

3.  Substantial changes in life: perceptions in patients with newly diagnosed advanced cancer and their spouses.

Authors:  Jeanette Winterling; Elisabet Wasteson; Bengt Glimelius; Per-Olow Sjödén; Karin Nordin
Journal:  Cancer Nurs       Date:  2004 Sep-Oct       Impact factor: 2.592

Review 4.  Construing benefits from adversity: adaptational significance and dispositional underpinnings.

Authors:  G Affleck; H Tennen
Journal:  J Pers       Date:  1996-12

5.  The initial development of an instrument to assess the psychosocial needs and unmet needs of young people who have a parent with cancer: piloting the offspring cancer needs instrument (OCNI).

Authors:  Pandora Patterson; Angela Pearce; Emma Slawitschka
Journal:  Support Care Cancer       Date:  2010-06-24       Impact factor: 3.603

6.  Post-traumatic growth and psychosocial adjustment of daughters of breast cancer survivors.

Authors:  Catherine E Mosher; Sharon Danoff-Burg; Beverly Brunker
Journal:  Oncol Nurs Forum       Date:  2006-05-03       Impact factor: 2.172

7.  Posttraumatic growth in prostate cancer survivors and their partners.

Authors:  Andrea A Thornton; Martin A Perez
Journal:  Psychooncology       Date:  2006-04       Impact factor: 3.894

8.  The Posttraumatic Growth Inventory: measuring the positive legacy of trauma.

Authors:  R G Tedeschi; L G Calhoun
Journal:  J Trauma Stress       Date:  1996-07

9.  Posttraumatic growth after breast cancer: patient, partner, and couple perspectives.

Authors:  Sharon Manne; Jamie Ostroff; Gary Winkel; Lori Goldstein; Kevin Fox; Generosa Grana
Journal:  Psychosom Med       Date:  2004 May-Jun       Impact factor: 4.312

10.  Appraisal of the cancer experience by family members and survivors in long-term survivorship.

Authors:  Karen F Bowman; Julia H Rose; Gary T Deimling
Journal:  Psychooncology       Date:  2006-09       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.